Aldeyra Therapeutics Inc. (NASDAQ:ALDX) went down by -5.07% from its latest closing price compared to the recent 1-year high of $12.23. The company’s stock price has collected -4.79% of loss in the last five trading sessions.
Is It Worth Investing in Aldeyra Therapeutics Inc. (NASDAQ :ALDX) Right Now?
Plus, the 36-month beta value for ALDX is at 1.43. Opinions of the stock are interesting as 9 analysts out of 9 who provided ratings for Aldeyra Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $20.78, which is $16.7 above the current price. ALDX currently public float of 47.35M and currently shorts hold a 7.17% ratio of that float. Today, the average trading volume of ALDX was 914.65K shares.
ALDX’s Market Performance
ALDX stocks went down by -4.79% for the week, with a monthly jump of 21.37% and a quarterly performance of -33.61%, while its annual performance rate touched -73.32%. The volatility ratio for the week stands at 7.94% while the volatility levels for the past 30 days are set at 8.77% for Aldeyra Therapeutics Inc. The simple moving average for the period of the last 20 days is -0.17% for ALDX stocks with a simple moving average of -41.77% for the last 200 days.
Analysts’ Opinion of ALDX
Many brokerage firms have already submitted their reports for ALDX stocks, with H.C. Wainwright repeating the rating for ALDX by listing it as a “Buy.” The predicted price for ALDX in the upcoming period, according to H.C. Wainwright is $15 based on the research report published on April 27th of the current year 2022.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see ALDX reach a price target of $26. The rating they have provided for ALDX stocks is “Buy” according to the report published on February 08th, 2021.
Berenberg gave a rating of “Buy” to ALDX, setting the target price at $32 in the report published on December 16th of the previous year.
ALDX Trading at -3.43% from the 50-Day Moving Average
After a stumble in the market that brought ALDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -74.00% of loss for the given period.
Volatility was left at 8.77%, however, over the last 30 days, the volatility rate increased by 7.94%, as shares surge +11.58% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -33.19% lower at present.
During the last 5 trading sessions, ALDX fell by -4.79%, which changed the moving average for the period of 200-days by -66.53% in comparison to the 20-day moving average, which settled at $3.20. In addition, Aldeyra Therapeutics Inc. saw -20.50% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ALDX
Equity return is now at value -29.80, with -26.40 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 19.77.